Botswana - Prevalence of HIV, female (% ages 15-24)

Prevalence of HIV, female (% ages 15-24) in Botswana was 8.80 as of 2020. Its highest value over the past 30 years was 23.60 in 1998, while its lowest value was 6.70 in 1990.

Definition: Prevalence of HIV, female is the percentage of females who are infected with HIV. Youth rates are as a percentage of the relevant age group.

Source: UNAIDS estimates.

See also:

Year Value
1990 6.70
1991 9.70
1992 13.00
1993 16.30
1994 19.30
1995 21.60
1996 23.00
1997 23.60
1998 23.60
1999 23.00
2000 22.00
2001 20.70
2002 19.30
2003 17.80
2004 16.40
2005 15.10
2006 13.90
2007 13.00
2008 12.20
2009 11.60
2010 11.20
2011 10.90
2012 10.60
2013 10.40
2014 10.30
2015 10.20
2016 10.10
2017 9.90
2018 9.60
2019 9.30
2020 8.80

Limitations and Exceptions: The limited availability of data on health status is a major constraint in assessing the health situation in developing countries. Surveillance data are lacking for many major public health concerns. Estimates of prevalence and incidence are available for some diseases but are often unreliable and incomplete. National health authorities differ widely in capacity and willingness to collect or report information.

Statistical Concept and Methodology: HIV prevalence rates reflect the rate of HIV infection in each country's population. Low national prevalence rates can be misleading, however. They often disguise epidemics that are initially concentrated in certain localities or population groups and threaten to spill over into the wider population. In many developing countries most new infections occur in young adults, with young women especially vulnerable. Data on HIV are from the Joint United Nations Programme on HIV/AIDS (UNAIDS). Changes in procedures and assumptions for estimating the data and better coordination with countries have resulted in improved estimates of HIV and AIDS. The models, which are routinely updated, track the course of HIV epidemics and their impact, making full use of information in HIV prevalence trends from surveillance data as well as survey data. The models take into account reduced infectivity among people receiving antiretroviral therapy (which is having a larger impact on HIV prevalence and allowing HIV-positive people to live longer) and allow for changes in urbanization over time in generalized epidemics. The estimates include plausibility bounds, which reflect the certainty associated with each of the estimates.

Aggregation method: Weighted average

Periodicity: Annual

General Comments: In many developing countries most new infections occur in young adults, with young women especially vulnerable.

Classification

Topic: Health Indicators

Sub-Topic: Risk factors